PTPI · Petros Pharmaceuticals, Inc. · Analyst Estimates
$0.05
-0.02 (-28.79%)
At close · May 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company does not have sufficient resources to fund its operations for the next twelve months from the date of this filing, management has substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$169,489
Shares
42.37M
Volume · May 22
10.28M
Avg daily vol (16 sessions)
38.33M
Analyst Estimates
Compare analyst forecasts for Petros Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 06:50 UTC · Publication dates shown per estimate · 2 metric / period groups
FY ending 2024-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|
Q ending 2025-03-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|